PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Prezista
Presentation Product Chemical substance Chapter Items dispensed
Prezista 100mg/ml oral suspension
0503010ACBBAFAF
Prezista Darunavir Infections No data available
Prezista 150mg tablets
0503010ACBBAEAE
Prezista Darunavir Infections No data available
Prezista 300mg tablets
0503010ACBBAAAA
Prezista Darunavir Infections No data available
Prezista 400mg tablets
0503010ACBBABAB
Prezista Darunavir Infections No data available
Prezista 600mg tablets
0503010ACBBACAC
Prezista Darunavir Infections No data available
Prezista 75mg tablets
0503010ACBBADAD
Prezista Darunavir Infections No data available
Prezista 800mg tablets
0503010ACBBAGAG
Prezista Darunavir Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.